ER, PR, and HER2/neu Testing in Breast Cancer: Quantifying the Value of Repeated Centralized Testing in Excision Specimens

被引：0
|
作者：
Hariri, Nosaibah [1 ]
Roma, Andres A. [1 ]
Hasteh, Farnaz [1 ]
Walavalkar, Vighnesh [1 ]
Fadare, Oluwole [1 ]
机构：
[1] Univ Calif San Diego, San Diego, CA USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
174
引用
收藏
页码：45A / 46A
页数：2
相关论文
共 50 条
  • [1] ER, PR, and HER2/neu Testing in Breast Cancer: Quantifying the Value of Repeated Centralized Testing in Excision Specimens
    Hariri, Nosaibah
    Roma, Andres A.
    Hasteh, Farnaz
    Walavalkar, Vighnesh
    Fadare, Oluwole
    MODERN PATHOLOGY, 2017, 30 : 45A - 46A
  • [2] Indicator measures ER/PR and HER2 testing among women with invasive breast cancer
    Sandoval, C.
    Rahal, R.
    Forte, T.
    Klein-Geltink, J.
    He, D.
    Bryant, H.
    CURRENT ONCOLOGY, 2013, 20 (01) : 62 - 63
  • [3] Advantages and Disadvantages of Technologies for HER2 Testing in Breast Cancer Specimens
    Furrer, Daniela
    Sanschagrin, Francois
    Jacob, Simon
    Diorio, Caroline
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (05) : 686 - 703
  • [4] Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer: Assessing the Value of Repeated Centralized Testing in Excision Specimens
    Hariri, Nosaibah
    Hasteh, Farnaz
    Walavalkar, Vighnesh
    Roma, Andres A.
    Fadare, Oluwole
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (01) : 1 - 7
  • [5] Accuracy and precision in HER2/neu testing in breast cancer: Are we there yet?
    Yaziji, H
    Gown, AM
    HUMAN PATHOLOGY, 2004, 35 (02) : 143 - 146
  • [6] Testing for HER2 in breast cancer
    Lewis, F
    Jackson, P
    Lane, S
    Coast, G
    Hanby, AM
    HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
  • [7] Current issues in ER and HER2 testing by IHC in breast cancer
    Gown, Allen M.
    MODERN PATHOLOGY, 2008, 21 : S8 - S15
  • [8] A Systematic Method of Assessing ER/PR/Her2 on Core Biopsy and or Excision Specimens
    Jaffer, Shabnam
    Reindl, Bailey A.
    Bleiweiss, Ira J.
    Nayak, Anupina
    MODERN PATHOLOGY, 2016, 29 : 47A - 47A
  • [9] A Systematic Method of Assessing ER/PR/Her2 on Core Biopsy and or Excision Specimens
    Jaffer, Shabnam
    Reindl, Bailey A.
    Bleiweiss, Ira J.
    Nayak, Anupma
    LABORATORY INVESTIGATION, 2016, 96 : 47A - 47A
  • [10] MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
    Radojicic, Jelena
    Zaravinos, Apostolos
    Vrekoussis, Thomas
    Kafousi, Maria
    Spandidos, Demetrios A.
    Stathopoulos, Efstathios N.
    CELL CYCLE, 2011, 10 (03) : 507 - 517
12345